Activator protein 2α associates with adenomatous polyposis coli/β-catenin and inhibits β-catenin/T-cell factor transcriptional activity in colorectal cancer cells

Qingjie Li, Roderick H. Dashwood

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

In most human colorectal cancers, mutations in the adenomatous polyposis coli gene (APC) or CTNNB1 constitutively activate the β-catenin/T-cell factor (TCF)/lymphoid enhancer factor (LEF) signaling pathway. Here, we show that the transcription factor activator protein (AP)-2α inhibited a β-catenin/TCF-responsive reporter in human embryonic kidney 293 cells and in two human colorectal cancer lines, despite the fact that β3-catenin and TCF-4 protein levels were unchanged in the nucleus. Co-immunoprecipitation studies revealed that AP-2α formed a complex with APC and β-catenin and that AP-2α disrupted β-catenin/TCF-4 interactions in the nucleus. Thus, AP-2α·APC·β-catenin complex formation appears to suppress β-catenin transactivation by shifting the pool of nuclear β-catenin toward an inactive form, having reduced binding to TCF/LEF transcription factors. Glutathione S-transferase pull-down assays showed that AP-2α physically associated with APC rather than with β-catenin, and the AP-2α binding site was identified in the N terminus of APC, involving both the heptad and armadillo repeat domains, whereas the APC binding site in AP-2α was in the basic region of the C-terminal DNA binding domain. These findings provide the first evidence for a specific interaction between the tumor suppressor protein APC and the transcription factor AP-2α, and they suggest a link between the Wnt signaling pathway and various other pathways of development and differentiation associated with AP-2α.

Original languageEnglish (US)
Pages (from-to)45669-45675
Number of pages7
JournalJournal of Biological Chemistry
Volume279
Issue number44
DOIs
StatePublished - Oct 29 2004
Externally publishedYes

Fingerprint

TCF Transcription Factors
Catenins
Adenomatous Polyposis Coli
APC Genes
Colorectal Neoplasms
Cells
Genes
Proteins
Transcription Factor 7-Like 2 Protein
Transcription Factors
Binding Sites
Armadillos
Tumor Suppressor Proteins
Wnt Signaling Pathway
Glutathione Transferase
Immunoprecipitation
Protein Binding
Transcriptional Activation
Assays
Kidney

ASJC Scopus subject areas

  • Biochemistry

Cite this

@article{2dd44127b270426cac467a10a536dbde,
title = "Activator protein 2α associates with adenomatous polyposis coli/β-catenin and inhibits β-catenin/T-cell factor transcriptional activity in colorectal cancer cells",
abstract = "In most human colorectal cancers, mutations in the adenomatous polyposis coli gene (APC) or CTNNB1 constitutively activate the β-catenin/T-cell factor (TCF)/lymphoid enhancer factor (LEF) signaling pathway. Here, we show that the transcription factor activator protein (AP)-2α inhibited a β-catenin/TCF-responsive reporter in human embryonic kidney 293 cells and in two human colorectal cancer lines, despite the fact that β3-catenin and TCF-4 protein levels were unchanged in the nucleus. Co-immunoprecipitation studies revealed that AP-2α formed a complex with APC and β-catenin and that AP-2α disrupted β-catenin/TCF-4 interactions in the nucleus. Thus, AP-2α·APC·β-catenin complex formation appears to suppress β-catenin transactivation by shifting the pool of nuclear β-catenin toward an inactive form, having reduced binding to TCF/LEF transcription factors. Glutathione S-transferase pull-down assays showed that AP-2α physically associated with APC rather than with β-catenin, and the AP-2α binding site was identified in the N terminus of APC, involving both the heptad and armadillo repeat domains, whereas the APC binding site in AP-2α was in the basic region of the C-terminal DNA binding domain. These findings provide the first evidence for a specific interaction between the tumor suppressor protein APC and the transcription factor AP-2α, and they suggest a link between the Wnt signaling pathway and various other pathways of development and differentiation associated with AP-2α.",
author = "Qingjie Li and Dashwood, {Roderick H.}",
year = "2004",
month = "10",
day = "29",
doi = "10.1074/jbc.M405025200",
language = "English (US)",
volume = "279",
pages = "45669--45675",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "44",

}

TY - JOUR

T1 - Activator protein 2α associates with adenomatous polyposis coli/β-catenin and inhibits β-catenin/T-cell factor transcriptional activity in colorectal cancer cells

AU - Li, Qingjie

AU - Dashwood, Roderick H.

PY - 2004/10/29

Y1 - 2004/10/29

N2 - In most human colorectal cancers, mutations in the adenomatous polyposis coli gene (APC) or CTNNB1 constitutively activate the β-catenin/T-cell factor (TCF)/lymphoid enhancer factor (LEF) signaling pathway. Here, we show that the transcription factor activator protein (AP)-2α inhibited a β-catenin/TCF-responsive reporter in human embryonic kidney 293 cells and in two human colorectal cancer lines, despite the fact that β3-catenin and TCF-4 protein levels were unchanged in the nucleus. Co-immunoprecipitation studies revealed that AP-2α formed a complex with APC and β-catenin and that AP-2α disrupted β-catenin/TCF-4 interactions in the nucleus. Thus, AP-2α·APC·β-catenin complex formation appears to suppress β-catenin transactivation by shifting the pool of nuclear β-catenin toward an inactive form, having reduced binding to TCF/LEF transcription factors. Glutathione S-transferase pull-down assays showed that AP-2α physically associated with APC rather than with β-catenin, and the AP-2α binding site was identified in the N terminus of APC, involving both the heptad and armadillo repeat domains, whereas the APC binding site in AP-2α was in the basic region of the C-terminal DNA binding domain. These findings provide the first evidence for a specific interaction between the tumor suppressor protein APC and the transcription factor AP-2α, and they suggest a link between the Wnt signaling pathway and various other pathways of development and differentiation associated with AP-2α.

AB - In most human colorectal cancers, mutations in the adenomatous polyposis coli gene (APC) or CTNNB1 constitutively activate the β-catenin/T-cell factor (TCF)/lymphoid enhancer factor (LEF) signaling pathway. Here, we show that the transcription factor activator protein (AP)-2α inhibited a β-catenin/TCF-responsive reporter in human embryonic kidney 293 cells and in two human colorectal cancer lines, despite the fact that β3-catenin and TCF-4 protein levels were unchanged in the nucleus. Co-immunoprecipitation studies revealed that AP-2α formed a complex with APC and β-catenin and that AP-2α disrupted β-catenin/TCF-4 interactions in the nucleus. Thus, AP-2α·APC·β-catenin complex formation appears to suppress β-catenin transactivation by shifting the pool of nuclear β-catenin toward an inactive form, having reduced binding to TCF/LEF transcription factors. Glutathione S-transferase pull-down assays showed that AP-2α physically associated with APC rather than with β-catenin, and the AP-2α binding site was identified in the N terminus of APC, involving both the heptad and armadillo repeat domains, whereas the APC binding site in AP-2α was in the basic region of the C-terminal DNA binding domain. These findings provide the first evidence for a specific interaction between the tumor suppressor protein APC and the transcription factor AP-2α, and they suggest a link between the Wnt signaling pathway and various other pathways of development and differentiation associated with AP-2α.

UR - http://www.scopus.com/inward/record.url?scp=8544272557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8544272557&partnerID=8YFLogxK

U2 - 10.1074/jbc.M405025200

DO - 10.1074/jbc.M405025200

M3 - Article

AN - SCOPUS:8544272557

VL - 279

SP - 45669

EP - 45675

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 44

ER -